Diabetes type | T1 | T2 | ||||
---|---|---|---|---|---|---|
Meeting the measure | TM–CAM− | TM–CAM + | TM + CAM + | TM–CAM− | TM-CAM + | TM + CAM + |
A. | LDL cholesterol | |||||
 n | 196 | 30 | 342 | 347 | 62 | 696 |
 Age (years), mean | 48 | 51 | 51 * | 69 | 71 | 69 |
 Diabetes duration (years), mean | 20 | 20 | 22 | 17 | 17 | 18 |
 Time before start insulin therapy (years), mean | 0.2 | 0.3 | 0.5 | 7.8 | 8.2 | 8.6 |
 Duration insulin therapy (years), mean | 20 | 20 | 21 | 9.2 | 8.4 | 9.2 |
 Smoking status (%) | ||||||
  Never smoked | 63.7 | 50.0 | 65.8 | 65.6 | 59.3 | 66.9 |
  Ex-smoker | 13.5 | 23.3 | 12.7 | 25.0 | 28.8 | 24.2 |
  Smoker | 22.8 | 26.7 | 21.5 | 9.4 | 11.9 | 8.9 |
 Presence of complication (%) | ||||||
  CV_hist1 (° for T2D) | 8.7 | 10.0 | 4.1 | 40.9 | 38.7 | 15.5 |
  CV_hist2 (° for T1D, ° for T2D) | 13.8 | 16.7 | 4.4 | 48.4 | 50.0 | 18.7 |
  CV_hist3 ($ for T1D, ° for T2D) | 15.4 | 18.5 | 6.2 | 52.4 | 55.2 | 24.2 |
  Microvascular complication | 51.6 | 60.9 | 53.8 | 71.7 | 81.8 | 73.2 |
  Absent foot pulses or abnormal sensitivity | 14.2 | 16.0 | 16.0 | 36.3 | 43.1 | 33.5 |
 Treated with (%) | ||||||
  Antiplatelet drugs (* for T1D) | 29.1 | 50.0 | 36.9 | 71.6 | 69.4 | 74.5 |
  Lipid-lowering drugs ($ for T1D, $ for T2D) | 32.6 | 93.3 | 50.9 | 71.5 | 93.5 | 83.5 |
  Antihypertensive drugs | 40.8 | 46.7 | 51.0 | 86.4 | 87.1 | 87.0 |
  Oral antidiabetic drugs (° for T2D) | 7.7 | 13.3 | 8.9 | 51.3 | 33.9 | 58.4 |
B. | non-HDL cholesterol | |||||
 n | 315 | 49 | 870 | 713 | 125 | 1349 |
 Age (years), mean | 47 | 49 | 50 $ | 69 | 70 | 70 |
 Diabetes duration (years), mean | 19 | 21 | 22 $ | 17 | 17 | 18 |
 Time before start insulin therapy (years), mean | 0.2 | 0.4 | 0.3 | 7.9 | 7.5 | 8.0 |
 Duration insulin therapy (years), mean | 18 | 21 | 22 ° | 8.9 | 8.7 | 9.5 |
 Smoking status (%) | ||||||
  Never smoked | 57.2 | 61.7 | 65.0 | 60.5 | 60.4 | 65.0 |
  Ex-smoker | 15.1 | 19.1 | 14.9 | 27.8 | 29.7 | 25.2 |
  Smoker | 27.6 | 19.1 | 20.0 | 11.7 | 9.9 | 9.8 |
 Presence of complication (%) | ||||||
  CV_hist1 (° for T1D, ° for T2D) | 9.5 | 8.2 | 4.0 | 37.5 | 40.3 | 17.4 |
  CV_hist2 (° for T1D, ° for T2D) | 12.4 | 10.2 | 5.3 | 45.7 | 55.2 | 21.1 |
  CV_hist3 ($ for T1D, ° for T2D) | 13.9 | 14.6 | 7.8 | 50.1 | 60.3 | 27.0 |
  Microvascular complication (* for T2D) | 52.1 | 73.0 | 53.8 | 74.7 | 85.3 | 73.9 |
  Absent foot pulses or abnormal sensitivity (* for T2D) | 12.0 | 15.4 | 14.8 | 37.0 | 43.3 | 32.4 |
 Treated with (%) | ||||||
  Antiplatelet drugs ($ for T1D) | 22.2 | 36.7 | 33.0 | 72.1 | 69.6 | 72.4 |
  Lipid-lowering drugs (° for T1D, ° for T2D) | 29.5 | 98.0 | 45.2 | 69.1 | 95.2 | 81.9 |
  Antihypertensive drugs ($ for T1D) | 35.9 | 44.9 | 45.8 | 84.9 | 83.9 | 86.2 |
  Oral antidiabetic drugs ($ for T2D) | 8.0 | 8.2 | 8.4 | 53.7 | 41.9 | 56.4 |